Predicted interactions involving protein MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki (IPI00003783) that score above 1.0

Click on the protein name for more information about the protein.

The Score column is the predicted score of interaction between the two proteins

Click on the Evidence link to view a breakdown of the information about the predicted interaction.

Key
Module Score	Databases
	Where interaction is observed in another database a link is provided: - BIND - DIP - HPRD O - OPHID

Protein 1 (?)	Protein 2 (?)	Name of Protein 2	Module Scores (?)				Scores (?)	Evidence (?)	Database (?)
MAP2K2	RAF1	RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase					1.14E5	Evidence	O
MAP2K2	BRAF	BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase					8.47E4	Evidence	O
MAP2K2	NRAS	NRAS, HRAS1: GTPase NRas precursor					9.58E3	Evidence
MAP2K2	MAPK3	MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3					9.49E3	Evidence	O
MAP2K2	RPS6KA5	RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5					3.18E3	Evidence
MAP2K2	RPS6KA3	RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3					850.0	Evidence
MAP2K2	GAPD	GAPDH, GAPD, CDABP0047, OK/SW-cl.12: Glyceraldehyde-3-phosphate dehydrogenase					343.0	Evidence
MAP2K2	AKT1	AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase					105.0	Evidence
MAP2K2	PRKCI	PRKCI, DXS1179E: Protein kinase C iota type					71.10	Evidence
MAP2K2	VAV1	VAV1, VAV: Proto-oncogene vav					62.90	Evidence
MAP2K2	IRAK1	IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1					53.3	Evidence
MAP2K2	PSMA3	PSMA3, PSC8: Proteasome subunit alpha type-3					51.60	Evidence
MAP2K2	JAK1						51.50	Evidence
MAP2K2	JAK2	JAK2: Tyrosine-protein kinase JAK2					51.50	Evidence
MAP2K2	SH3BP2	SH3BP2: Uncharacterized protein SH3BP2					43.60	Evidence
MAP2K2	LCK	LCK: Proto-oncogene tyrosine-protein kinase LCK					43.60	Evidence	O
MAP2K2	HSP90AA1	Hsp89-alpha-delta-N					43.00	Evidence
MAP2K2	STAT5A	STAT5A, STAT5: Signal transducer and activator of transcription 5A					38.10	Evidence
MAP2K2	SQSTM1	SQSTM1: Uncharacterized protein SQSTM1					34.80	Evidence
MAP2K2	CDC25A	CDC25A: M-phase inducer phosphatase 1					33.90	Evidence
MAP2K2	SPTBN1	SPTBN1, SPTB2: Spectrin beta chain, brain 1					33.90	Evidence
MAP2K2	PDPK1	PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1					33.90	Evidence
MAP2K2	LYN	LYN: Tyrosine-protein kinase Lyn					32.80	Evidence
MAP2K2	DOCK2	DOCK2, KIAA0209: Dedicator of cytokinesis protein 2					31.70	Evidence
MAP2K2	MAPK1	MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1					31.70	Evidence	O
MAP2K2	NAP1L1	NAP1L1, NRP: Nucleosome assembly protein 1-like 1					31.40	Evidence
MAP2K2	CFLAR	CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec					29.00	Evidence
MAP2K2	RB1	RB1: Retinoblastoma-associated protein					28.30	Evidence
MAP2K2	RAP1A	RAP1A, KREV1: Ras-related protein Rap-1A precursor					26.90	Evidence
MAP2K2	ADRBK1	ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1					26.80	Evidence
MAP2K2	SYK	SYK: Tyrosine-protein kinase SYK					26.80	Evidence
MAP2K2	SRC	SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src					26.40	Evidence
MAP2K2	TRAF1	TRAF1, EBI6: TNF receptor-associated factor 1					22.50	Evidence
MAP2K2	PRKCZ	PRKCZ, PKC2: Protein kinase C zeta type					22.20	Evidence
MAP2K2	IL2RB	IL2RB: Interleukin-2 receptor subunit beta precursor					22.00	Evidence
MAP2K2	ARHGEF7	N/A					20.50	Evidence
MAP2K2	DUSP6	DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6					20.50	Evidence
MAP2K2	FYN	FYN: Proto-oncogene tyrosine-protein kinase Fyn					20.50	Evidence
MAP2K2	PARD6A	PARD6A, PAR6A: Partitioning defective 6 homolog alpha					20.50	Evidence
MAP2K2	MAP3K10	MAP3K10, MLK2, MST: Mitogen-activated protein kinase kinase kinase 10					20.40	Evidence
MAP2K2	STMN1	STMN1, LAP18, OP18: Stathmin					20.40	Evidence
MAP2K2	YWHAQ	YWHAQ: 14-3-3 protein theta					19.90	Evidence
MAP2K2	PTPRR	PTPRR, ECPTP, PTPRQ: Receptor-type tyrosine-protein phosphatase R precursor					19.70	Evidence
MAP2K2	STK3	STK3, MST2: Serine/threonine-protein kinase 3					19.70	Evidence
MAP2K2	IL6ST	IL6ST: Interleukin-6 receptor subunit beta precursor					19.10	Evidence
MAP2K2	ABI1	ABI1, SSH3BP1: Abl interactor 1					19.10	Evidence
MAP2K2	MAPK10	MAPK10, JNK3, JNK3A, PRKM10: Mitogen-activated protein kinase 10					19.10	Evidence
MAP2K2	FRS3	FRS3: Fibroblast growth factor receptor substrate 3					18.90	Evidence
MAP2K2	SH3BP5	N/A					18.90	Evidence
MAP2K2	PLK1	PLK1, PLK: Serine/threonine-protein kinase PLK1					18.30	Evidence
MAP2K2	XPO1	XPO1, CRM1: Exportin-1					17.80	Evidence
MAP2K2	COPS3	COPS3, CSN3: COP9 signalosome complex subunit 3					17.80	Evidence
MAP2K2	DUSP16	DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16					17.60	Evidence
MAP2K2	PTPRE	PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor					17.60	Evidence
MAP2K2	PTPRC	PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ					17.60	Evidence
MAP2K2	STAT3						17.60	Evidence
MAP2K2	IPO7	IPO7: Uncharacterized protein IPO7					16.10	Evidence
MAP2K2	DUSP1	DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1					15.60	Evidence
MAP2K2	HSF1	HSF1, HSTF1: Heat shock factor protein 1					15.30	Evidence
MAP2K2	RBL2	RBL2, RB2: Retinoblastoma-like protein 2					15.30	Evidence
MAP2K2	MGMT	MGMT: Methylated-DNA--protein-cysteine methyltransferase					15.10	Evidence
MAP2K2	EPOR	EPOR: Erythropoietin receptor precursor					15.10	Evidence
MAP2K2	CD44	N/A					15.10	Evidence
MAP2K2	GAB1	GAB1: GRB2-associated-binding protein 1					14.70	Evidence
MAP2K2	IRS1	IRS1: Insulin receptor substrate 1					14.70	Evidence
MAP2K2	TBCE	TBCE: Tubulin-specific chaperone E					14.40	Evidence
MAP2K2	RAN	RAN, ARA24, OK/SW-cl.81: GTP-binding nuclear protein Ran					13.20	Evidence
MAP2K2	TBXA2R	TBXA2R: Thromboxane A2 receptor					11.90	Evidence
MAP2K2	MAP3K5	MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5					11.80	Evidence
MAP2K2	MAPK7	mitogen-activated protein kinase 7 isoform 1					11.80	Evidence
MAP2K2	GRB10	N/A					11.70	Evidence
MAP2K2	SNCG	SNCG, BCSG1, PERSYN, PRSN: Gamma-synuclein					11.70	Evidence
MAP2K2	AGTR1	AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor					11.30	Evidence
MAP2K2	MAP2K1	MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1					10.60	Evidence
MAP2K2	YWHAZ	YWHAZ: 14-3-3 protein zeta/delta					10.60	Evidence
MAP2K2	PKN2	PKN2, PRK2, PRKCL2: Serine/threonine-protein kinase N2					10.60	Evidence
MAP2K2	PBK	PBK, TOPK: Lymphokine-activated killer T-cell-originated protein kinase					10.60	Evidence
MAP2K2	STK10	STK10: Uncharacterized protein STK10					10.60	Evidence
MAP2K2	YWHAB	YWHAB: 14-3-3 protein beta/alpha					10.60	Evidence
MAP2K2	STMN2	STMN2, SCG10, SCGN10: Stathmin-2					10.40	Evidence
MAP2K2	PLCB1	PLCB1, KIAA0581: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-					10.40	Evidence
MAP2K2	SORBS3	SORBS3, SCAM1: Vinexin					10.30	Evidence
MAP2K2	GRIK2	GRIK2, GLUR6: Glutamate receptor, ionotropic kainate 2 precursor					10.10	Evidence
MAP2K2	PDGFRB	PDGFRB: Beta-type platelet-derived growth factor receptor precursor					10.10	Evidence
MAP2K2	CASP9	CASP9, MCH6: Caspase-9 precursor					9.96	Evidence
MAP2K2	AMPH	AMPH, AMPH1: Amphiphysin					9.96	Evidence
MAP2K2	MAPK8	MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8					9.96	Evidence
MAP2K2	CREBBP	CREBBP, CBP: CREB-binding protein					9.91	Evidence
MAP2K2	JUND	JUND: Transcription factor jun-D					9.77	Evidence
MAP2K2	KIAA0528	KIAA0528: Uncharacterized protein KIAA0528					9.76	Evidence
MAP2K2	BAD	BAD, BBC6, BCL2L8: Bcl2 antagonist of cell death					9.32	Evidence
MAP2K2	JUN	JUN: Transcription factor AP-1					9.29	Evidence
MAP2K2	GNB2	GNB2: Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2					9.15	Evidence
MAP2K2	PRKCE	PRKCE, PKCE: Protein kinase C epsilon type					9.06	Evidence
MAP2K2	ADAM33	ADAM33, UNQ873/PRO1891: ADAM 33 precursor					8.92	Evidence
MAP2K2	ATP1A1	ATP1A1: Sodium/potassium-transporting ATPase subunit alpha-1 precursor					8.92	Evidence
MAP2K2	BCL2	BCL2: Apoptosis regulator Bcl-2					8.91	Evidence
MAP2K2	CENTA1	CENTA1: Centaurin-alpha 1					8.79	Evidence
MAP2K2	CDK4	CDK4: Cell division protein kinase 4					8.74	Evidence
MAP2K2	RPS6KA1	RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1					8.74	Evidence
MAP2K2	PA2G4	PA2G4, EBP1: Proliferation-associated protein 2G4					8.49	Evidence
MAP2K2	TUBB	TUBB, TUBB5, OK/SW-cl.56: Tubulin beta chain					7.94	Evidence
MAP2K2	PEBP1	PEBP1, PBP, PEBP: Phosphatidylethanolamine-binding protein 1					7.87	Evidence
MAP2K2	PRKCA	PRKCA, PKCA, PRKACA: Protein kinase C alpha type					7.73	Evidence
MAP2K2	ADAM23	ADAM23, MDC3: ADAM 23 precursor					7.72	Evidence
MAP2K2	DUSP3	DUSP3, VHR: Dual specificity protein phosphatase 3					7.71	Evidence
MAP2K2	PTPN11	N/A					7.52	Evidence
MAP2K2	ACTG1	ACTB: Actin, cytoplasmic 1					7.52	Evidence
MAP2K2	RAP1GA1	N/A					7.40	Evidence
MAP2K2	PRKAA1	N/A					7.39	Evidence
MAP2K2	NOL1	N/A					7.38	Evidence
MAP2K2	CHUK	N/A					7.20	Evidence
MAP2K2	PTPRA	N/A					7.14	Evidence
MAP2K2	ARRB2	N/A					6.83	Evidence
MAP2K2	DAPK1	DAPK1, DAPK: Death-associated protein kinase 1					6.66	Evidence
MAP2K2	CDK5R1	CDK5R1, CDK5R, NCK5A: Cyclin-dependent kinase 5 activator 1 precursor					6.63	Evidence
MAP2K2	GRK5	GRK5, GPRK5: G protein-coupled receptor kinase 5					6.62	Evidence
MAP2K2	PI4KII	PI4K2A: Phosphatidylinositol 4-kinase type 2-alpha					6.62	Evidence
MAP2K2	PEA15	PEA15: Astrocytic phosphoprotein PEA-15					6.55	Evidence
MAP2K2	YWHAG	YWHAG: 14-3-3 protein gamma					6.40	Evidence
MAP2K2	C9orf88	N/A					6.40	Evidence
MAP2K2	STAP2	Uncharacterized protein ENSP00000317912					6.40	Evidence
MAP2K2	PKP4	PKP4: Plakophilin-4					6.40	Evidence
MAP2K2	MTMR3	MTMR3, KIAA0371, ZFYVE10: Myotubularin-related protein 3					6.31	Evidence
MAP2K2	MINK1	MAP4K6, MINK1, MINK: Misshapen-like kinase 1					6.24	Evidence
MAP2K2	CENTB5	KIAA1716, CENTB5: Centaurin-beta 5					6.11	Evidence
MAP2K2	RASGRF2	RASGRF2: Ras protein-specific guanine nucleotide-releasing factor 2 (Fragment)					6.11	Evidence
MAP2K2	DOK5	DOK5, C20orf180: Docking protein 5					6.11	Evidence
MAP2K2	NR3C1	NR3C1, GRL: Glucocorticoid receptor					6.08	Evidence
MAP2K2	ETS1	ETS1, EWSR2: Protein C-ets-1					6.07	Evidence
MAP2K2	NGFR	NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor					5.90	Evidence
MAP2K2	HSPB8	HSPB8, CRYAC, PP1629, E2IG1, HSP22: Heat shock protein beta-8					5.86	Evidence
MAP2K2	RARS	RARS: Arginyl-tRNA synthetase, cytoplasmic					5.74	Evidence
MAP2K2	RSU1	RSU1, RSP1: Ras suppressor protein 1					5.73	Evidence
MAP2K2	PRKACA	PRKACA, PKACA: cAMP-dependent protein kinase, alpha-catalytic subunit					5.73	Evidence
MAP2K2	DIP13B	APPL2, DIP13B: DCC-interacting protein 13-beta					5.62	Evidence
MAP2K2	COPA	COPA: Coatomer subunit alpha					5.55	Evidence
MAP2K2	FKBP1A	FKBP1A, FKBP1, FKBP12: FK506-binding protein 1A					5.55	Evidence
MAP2K2	RAB4A	N/A					5.55	Evidence
MAP2K2	TH	TH, TYH: Tyrosine 3-monooxygenase					5.50	Evidence
MAP2K2	RANBP1	RANBP1: Ran-specific GTPase-activating protein					5.47	Evidence
MAP2K2	CLTC	CLTC, CLH17, CLTCL2, KIAA0034: Clathrin heavy chain 1					5.45	Evidence
MAP2K2	SGK	SGK, SGK1: Serine/threonine-protein kinase Sgk1					5.28	Evidence
MAP2K2	YWHAE	YWHAE: 14-3-3 protein epsilon					5.28	Evidence
MAP2K2	GNA13	GNA13: Guanine nucleotide-binding protein alpha-13 subunit					5.28	Evidence
MAP2K2	ACTN1	ACTN1: Alpha-actinin-1					5.28	Evidence
MAP2K2	GYS1	GYS1, GYS: Glycogen [starch] synthase, muscle					5.19	Evidence
MAP2K2	TOP2B	N/A					4.99	Evidence
MAP2K2	CEBPB	CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta					4.94	Evidence
MAP2K2	GRK1	GRK1, RHOK: Rhodopsin kinase precursor					4.77	Evidence
MAP2K2	TCF3	TCF3, E2A, ITF1: Transcription factor E2-alpha					4.77	Evidence
MAP2K2	FRS2	FRS2: Fibroblast growth factor receptor substrate 2					4.77	Evidence
MAP2K2	MAPK14	MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2: Mitogen-activated protein kinase 14					4.50	Evidence
MAP2K2	UBTF	UBTF, UBF, UBF1: Nucleolar transcription factor 1					4.30	Evidence
MAP2K2	STUB1	STUB1, CHIP, PP1131: STIP1 homology and U box-containing protein 1					4.23	Evidence
MAP2K2	GPA33	GPA33: Cell surface A33 antigen precursor					4.21	Evidence
MAP2K2	YWHAH	YWHAH, YWHA1: 14-3-3 protein eta					4.21	Evidence
MAP2K2	C1QBP	C1QBP, GC1QBP, HABP1, SF2P32: Complement component 1 Q subcomponent-binding prot					4.19	Evidence
MAP2K2	GJA1	GJA1, GJAL: Gap junction alpha-1 protein					4.04	Evidence
MAP2K2	NFKBIA	NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha					4.01	Evidence
MAP2K2	MYCN	MYCN, NMYC: N-myc proto-oncogene protein					3.98	Evidence
MAP2K2	CCNG2	CCNG2: Cyclin-G2					3.96	Evidence
MAP2K2	RRAS	RRAS: Ras-related protein R-Ras precursor					3.93	Evidence
MAP2K2	ELK1	ELK1: ETS domain-containing protein Elk-1					3.92	Evidence
MAP2K2	CDC42	N/A					3.88	Evidence
MAP2K2	TP53	TP53, P53: Cellular tumor antigen p53					3.85	Evidence
MAP2K2	SMAD2	SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2					3.85	Evidence
MAP2K2	CEACAM1	CEACAM1, BGP, BGP1: Carcinoembryonic antigen-related cell adhesion molecule 1 pr					3.79	Evidence
MAP2K2	PRKG1	PRKG1, PRKG1B, PRKGR1B: cGMP-dependent protein kinase 1, beta isozyme					3.77	Evidence
MAP2K2	OSBPL6	OSBPL6, ORP6: Oxysterol-binding protein-related protein 6					3.70	Evidence
MAP2K2	MAP2K5	N/A					3.57	Evidence
MAP2K2	TRAF5	TRAF5, RNF84: TNF receptor-associated factor 5					3.52	Evidence
MAP2K2	TRAF6	TRAF6, RNF85: TNF receptor-associated factor 6					3.52	Evidence
MAP2K2	RAC1	N/A					3.47	Evidence
MAP2K2	RPS6KA2	RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2					3.47	Evidence
MAP2K2	LRRC7	LRRC7, KIAA1365, LAP1: Leucine-rich repeat-containing protein 7					3.47	Evidence
MAP2K2	MKNK1	MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1					3.47	Evidence
MAP2K2	DUSP2	DUSP2, PAC1: Dual specificity protein phosphatase 2					3.41	Evidence
MAP2K2	INSR	INSR: Insulin receptor precursor					3.4	Evidence
MAP2K2	PTPN7	N/A					3.34	Evidence
MAP2K2	DUSP10	DUSP10, MKP5: Dual specificity protein phosphatase 10					3.31	Evidence
MAP2K2	PARD6G	PARD6G, PAR6G: Partitioning defective 6 homolog gamma					3.31	Evidence
MAP2K2	ARAF	ARAF, ARAF1, PKS, PKS2: A-Raf proto-oncogene serine/threonine-protein kinase					3.28	Evidence	O
MAP2K2	ARHGEF1	ARHGEF1: Rho guanine nucleotide exchange factor 1					3.18	Evidence
MAP2K2	MAPK12	MAPK12, ERK6, SAPK3: Mitogen-activated protein kinase 12					3.17	Evidence
MAP2K2	MAPK13	MAPK13, PRKM13, SAPK4: Mitogen-activated protein kinase 13					3.17	Evidence
MAP2K2	NHP2L1	NHP2L1: NHP2-like protein 1					3.12	Evidence
MAP2K2	MAP3K14	MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14					3.07	Evidence
MAP2K2	NRAS	HRAS, HRAS1: GTPase HRas precursor					3.03	Evidence
MAP2K2	KRT8	KRT8, CYK8: Keratin, type II cytoskeletal 8					3.00	Evidence
MAP2K2	RPS6KA4	RPS6KA4, MSK2: Ribosomal protein S6 kinase alpha-4					2.99	Evidence
MAP2K2	MAP2K3	N/A					2.99	Evidence
MAP2K2	FAM53C	N/A					2.8	Evidence
MAP2K2	GRIN2B	GRIN2B, NMDAR2B: Glutamate [NMDA] receptor subunit epsilon-2 precursor					2.48	Evidence
MAP2K2	HIF1A	HIF1A, MOP1: Hypoxia-inducible factor 1 alpha					2.33	Evidence
MAP2K2	PARD3	N/A					2.28	Evidence
MAP2K2	KRT18	KRT18: Uncharacterized protein KRT18					2.15	Evidence
MAP2K2	RHEB	RHEB, RHEB2: GTP-binding protein Rheb precursor					2.05	Evidence
MAP2K2	PDHA1	PDHA1, PHE1A: Pyruvate dehydrogenase E1 component subunit alpha, somatic form, m					1.97	Evidence	O
MAP2K2	DUSP4	DUSP4, MKP2, VH2: Dual specificity protein phosphatase 4					1.94	Evidence
MAP2K2	TAL2	TAL2: T-cell acute lymphocytic leukemia protein 2					1.78	Evidence
MAP2K2	HDAC4	HDAC4, KIAA0288: Histone deacetylase 4					1.76	Evidence
MAP2K2	TAL1	TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1					1.76	Evidence
MAP2K2	NFIA	NFIA, RP5-902P15.1-003, hCG_2032260: Nuclear factor I/A					1.71	Evidence
MAP2K2	RAVER1	RAVER1, KIAA1978: Ribonucleoprotein PTB-binding 1					1.71	Evidence
MAP2K2	MAPT	N/A					1.39	Evidence
MAP2K2	RAP2A	RAP2A: Ras-related protein Rap-2a precursor					1.27	Evidence
MAP2K2	PPARA	PPARA, NR1C1, PPAR: Peroxisome proliferator-activated receptor alpha					1.27	Evidence
MAP2K2	NR4A2	NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2					1.17	Evidence
MAP2K2	ESR1	ESR1, ESR, NR3A1: Estrogen receptor					1.14	Evidence
MAP2K2	RHOQ	RHOQ, ARHQ, RASL7A, TC10: Rho-related GTP-binding protein RhoQ precursor					1.14	Evidence
MAP2K2	CARD14	CARD14, CARMA2: Caspase recruitment domain-containing protein 14					1.13	Evidence
MAP2K2	TRAF2	N/A					1.07	Evidence
MAP2K2	SPAG9	N/A					1.07	Evidence
MAP2K2	MARK4	N/A					1.04	Evidence